SCHEMBL3342810

SCHEMBL3342810

Cc1cc(-c2ccc(C)c(C(N)=O)c2)no1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.49
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
RAB9A P51151 7/20 0.41
NPC1 O15118 5/20 0.41
ALDH1A1 P00352 7/20 0.40
KDM4E B2RXH2 3/20 0.40
HPGD P15428 1/20 0.40
SYK P43405 2/20 0.40
SIRT3 Q9NTG7 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
HTT P42858 1/20 0.38
GAA P10253 2/20 0.37
MAPT P10636 2/20 0.37
AGTR1 P30556 1/20 0.37
USP2 O75604 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3342157 0.76 LMNA (0.47) POLBALDH1A1KDM4EMAPTUSP2
SCHEMBL3342816 0.76 RAB9A (0.45) POLBCA2CA7RAB9ANPC1
SCHEMBL3346644 0.75 CHEK2 (0.49) SYKSIRT3TDP1MKNK1MKNK2
SCHEMBL3347858 0.74 P2RX7 (0.44) SYKSIRT3TDP1MKNK1MKNK2
SCHEMBL3346669 0.73 MKNK1 (0.53) KDM4ESYKSIRT3TDP1MKNK1
SCHEMBL3342192 0.73 ALPL (0.49) RAB9ANPC1KDM4EGAAMAPT
SCHEMBL3342673 0.73 ALPL (0.39) SYKSIRT3TDP1MKNK1MKNK2
SCHEMBL3342845 0.73 ABL1 (0.45) SYKSIRT3TDP1MKNK1MKNK2
SCHEMBL3342952 0.73 P2RX7 (0.46) SYKSIRT3TDP1MKNK1MKNK2
SCHEMBL3468663 0.72 GSK3B (0.50) RAB9ANPC1ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 POLB 4104/4885CA2 2648/4885CA7 4808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.